Degree of histological differentiation is an important characteristic of cancers and may be associated with malignant potential. However, in squamous cell carcinomas, a key transcriptional factor regulating tumor differentiation is largely unknown. Chemoradiotherapy (CRT) is a standard treatment for locally advanced esophageal squamous cell carcinoma; however, the survival rate is still below 40%. From microarray data, single-minded 2 (SIM2) was overexpressed in the epithelial subtype. Here, we 
| INTRODUCTION
Esophageal cancer is the sixth most common cause of cancer deaths worldwide. 1 Neoadjuvant chemotherapy (CT) or neoadjuvant chemoradiotherapy (CRT) followed by esophagectomy, or definitive CRT have been standard initial treatments for locally advanced esophageal squamous cell carcinoma (ESCC) in Asia and Western countries. Although improvement in neoadjuvant CT and definitive CRT has been achieved, the 5-year survival rate of locally advanced ESCC is still 37%-55% as a result of local recurrence, lymph node metastasis, and distant metastasis. 2, 3 Therefore, further investigation into the progression and treatment resistance of ESCC is needed.
Degree of tumor differentiation is the major histopathological classification factor in squamous cell carcinoma such as ESCC, head and neck squamous cell carcinoma (HNSCC) and uterine cervical squamous cell carcinoma and has many similarities in therapeutic strategy. In squamous cell carcinoma, the differentiation degree has been thought to influence treatment sensitivity and prognosis, as is shown in several reports on their relationship. Broders classified genito-urinary cancer including squamous cell carcinoma by the ratio of differentiated cells and undifferentiated cells, and the undifferentiated histology presented a poor prognosis. 4 Histological grade including keratinization of HNSCC was reported to influence prognosis. 5 Additionally, histological differentiation was reported to be correlated with local recurrence in squamous cell carcinoma of the skin, ear and lip. 6 However, it is unknown whether this factor is associated with the response to neoadjuvant therapy, because study using pretreatment biopsy samples has been limited. Furthermore, no key transcription factor involved in the differentiation of squamous cell carcinoma has been reported. By comparing gene expression profiles among pre-and post-treatment biopsy specimens of 30 ESCC patients and 121 pretreatment ESCC biopsy specimens, we recently discovered a good responder subtype of ESCC with cytotoxic T-lymphocyte signatures activated by CRT. 7 In the complete response (CR) cases, 999 overexpressed genes including at least 234 tumor-specific CTL activation-associated genes such as IFNG, PRF1, and GZMB, were found in post-treatment biopsy specimens. Clustering analysis using expression profiles of these 234 genes in 121 pretreatment ESCC allowed us to distinguish the immune-activated cases, designating them as I-type, from other cases. Further comparative study identified a series of epithelialmesenchymal transition (EMT)-related genes overexpressed in early relapse cases. Clinical outcome of CDH2-negative epithelial cases in the I-type was significantly better than that of CDH2-positive mesenchymal cases in the I-type (64% vs 12% in 5-year overall survival). Interestingly, SIM2 was found to be overexpressed in CDH2-negative epithelial cases in the I-type as shown in Table S7 of our previous paper. 7 Single-minded 2 (SIM2) is located in a minimum region of chromosome 21 often implicated in Down syndrome called Down syndrome chromosomal region, and is a member of the basic HLH (helix-loop-helix)-PER-ARNT-SIM (bHLH-PAS) family. 8 SIM2 is comparable with other bHLH-PAS family members, hypoxia inducible factor alpha (HIF1a) and aryl hydrocarbon receptor (AHR), for binding to the partner, aryl hydrocarbon receptor nuclear translocator (ARNT) or ARNT2. SIM2-ARNT dimer binds to central midline elements (CME) in the regulatory regions of target genes and actively represses gene expression through the carboxy-terminal transrepression domain of SIM2. [9] [10] [11] In addition, SIM2-ARNT dimer is capable of binding not only to CME but also to hypoxia-response elements that is normally bound by HIF-1a. 12 There are two different spliced isoforms of human SIM2, SIM2-long (SIM2) and SIM2-short (SIM2s), which differ in their 3 0 ends. 8 In mice, Sim2s has been reported to exert a less repressive effect on hypoxia-induced gene expression than does Sim2, and Sim2s binds to CME and activates expression of the CME-controlled reporter gene through an Arnt transactivation domain-dependent mechanism. 13 However, their differential functions in humans are yet unknown.
Substantial misregulation of SIM2 expression has been reported in several cancer types. [14] [15] [16] [17] In breast cancer, SIM2s directly downregulates SNAI2 expression and inhibits EMT, and represses tumor growth and invasion. 15, 18, 19 In addition, Sim2s increases the expression of genes that are associated with mammary lactogenic differentiation in mice. 20 Conversely, knockdown of SIM2s causes growth inhibition and increases cell death through apoptosis in cultured colon carcinoma and pancreatic carcinoma cell lines, 14, 16, 21 and decreases growth of colon carcinoma-derived xenograft. 8 Increased expression of SIM2s and SIM2 is notably associated with the development and progression of prostate tumor. 17, 22, 23 Thus, the expression and the role of SIM2 and SIM2s are dependent on the tumor type. In this study, we showed the functional role of SIM2 and its clinical implications in squamous cell carcinoma, particularly in ESCC. 
| MATERIALS AND METHODS

| Clinical samples
| Cell culture
Esophageal cancer cell lines (TE1, TE3, TE5, TE6, TE8, TE10, KYSE510, and T.Tn), were purchased from the Japanese Collection ). Primers used for the study are listed in Table S1 .
| 5-Azacytidine treatment
Cells were plated at 2 9 10 6 cells per 10-cm dish. One day after plating, the cells were treated with 5-azacytidine (AzaC, 2 lmol/L; Focus Biomolecules, Plymouth Meeting, PA, USA) for 48 hours.
| Bisulfite sequence
Bisulfite modification of DNA isolated from 10 pairs of esophageal cancer tissues and their matched non-cancerous tissues was conducted by using MethylEasy Xceed (Human Genetic Signatures, Sydney, Australia) according to the manufacturer's protocol. PCR for bisulfite-treated DNA was done by carrying out 40 cycles using EpiTaq HS (TaKaRa, Ohtsu, Japan) with primers for the SIM2 promoter.
Sequencing was carried out by Eurofins Genomics Inc. (Tokyo, Japan). Primers used for the study are listed in Table S2 . 
| Immunocytochemistry
Specimens fixed in formalin and embedded in paraffin were cut 
| Animal experiment
The protocol for the animal experiments was approved by the committee for Ethics of Animal Experimentation and was in accordance with the Guideline for Animal Experiments at the National Cancer
Center. SIM2 overexpressing cells (5 9 10 6 cells) were transplanted into subcutaneous spaces at three sites in the backs of 6-week-old female C.B17/Icr-scid (scid/scid) mice. Tumor growth was observed for 3-11 weeks. Two mice were used for each group.
| Immunofluorescence analysis
Cells were grown on glass chamber slides, fixed with 4% paraformaldehyde, permeabilized with À20°C methanol and 0.5% Eluted proteins were fractionated by SDS-PAGE and detected by western blot.
| Western blot
Samples were separated using SDS-PAGE (7.5% acrylamide). Proteins were transferred to a nitrocellulose membrane and blocked with 5% membrane blocking agent (GE Healthcare, Buckinghamshire, UK) in PBS, and probed with anti-SIM2 antibody 
| CDDP treatment
Mock-or SIM2-transfectants were plated at 2 9 10 5 cells per 3. 
| Statistical analysis
All data are expressed as the mean + SE, and analyzed using the unpaired t test. In clinical outcome data, P-values were calculated by log-rank analysis. P-values <.05 were considered significant. EkuseruToukei 2010 (Social Survey Research Information Co., Ltd, Tokyo, Japan) was used for all statistical analyses.
3 | RESULTS
| SIM2 is frequently underexpressed in ESCC by promoter methylation
First, by quantitative real-time PCR, we compared the mRNA expression levels of SIM2, ARNT and ARNT2 between cancerous and noncancerous tissues of 60 ESCC patients who underwent esophagectomy. In 90% of them, SIM2 was suppressed in the cancerous tissues as compared with the non-cancerous tissues ( Figure 1A , upper). In contrast, no or quite low SIM2s mRNA was detected in both the cancerous and non-cancerous tissues by RT-PCR (data not shown).
Both ARNT and ARNT2 mRNAs slightly increased in the cancerous tissues, but ARNT2 mRNA levels were quite low in both the cancerous and non-cancerous tissues (Figure 1A , lower; Figure S1 ). Next, we examined SIM2 expression in 85 ESCC biopsy specimens before definitive CRT and in 4 normal specimens. In 93% of 85 ESCC, SIM2
was underexpressed compared with the average of the 4 normal specimens ( Figure 1B) . Importantly, the upper 30% of patients in the SIM2 expression level showed a favorable prognosis compared to the lower 30% of patients ( Figure 1C ). To address the relationship between SIM2 expression and promoter methylation, we examined (Figure 2A ; Figure S2 ). SIM2 mRNA level was quite low in TE10 only (Figure 2A ). Transcription start site of SIM2 is localized at 1.2 kb upstream of the translation initiation site, and the SIM2 promoter region is reported to be GC-rich. 24 To examine whether promoter methylation is involved in the suppression of EMT markers (FN1 and VIM), and a basal cell marker (PDPN).
25-28
Overexpression of SIM2s did not affect expression of all of the genes, whereas overexpression of SIM2 repressed SNAI2 and TWIST1 expression, but did not affect FN1, VIM or PDPN ( Figure 3A) .
To examine the effect of SIM2 on cell differentiation, we next used a 3D culture system which was reported to induce differentiation of squamous cell carcinoma through adhesion restriction. 29 Before the SIM2 cDNA transfection experiment, we confirmed both an increase and a decrease of mRNA of differentiation markers (CEA, FLG, IVL, KRT1, LOR, and SPRR1A) and EMT/basal cell markers (VIM and PDPN), respectively, [25] [26] [27] [28] in KYSE510, TE8, and T.Tn by the 3D culture (Figure S3) . Overexpression of SIM2 in KYSE510, TE8 and T.Tn followed by the 3D culture appeared to increase spheroid formation more White circle signifies that the cytosine signal is higher than the thymidine signal. Light green circle signifies that the cytosine signal is higher than half of the thymidine signal but lower than the thymidine signal. Green circle signifies that the cytosine signal is lower than half of the thymidine signal. Dotted circle, not informative effectively than did the control ( Figure 3B ). Overexpression of SIM2 in KYSE510 and TE8 significantly increased SPRR1A mRNA and decreased VIM and PDPN mRNA at day 3 or 5, and that in T.Tn significantly induced FLG and repressed VIM ( Figure 3C ). No effect of 3D culture in SIM2 mRNA level was observed in these three cell lines (Figure S3B ). These results of in vitro 3D cultures suggest that SIM2 has an important role as an ESCC differentiation inducer.
| SIM2 inhibits self-renewal of PDPN-positive tumor basal cells
To investigate in vitro long term and the in vivo effect of SIM2 in ESCC cells, we established transfectants stably expressing SIM2, KYSE510-SIM2-27, KYSE510-SIM2-37, TE8-SIM2-2, TE8-SIM2-3,
T.Tn-SIM2-9, and T.Tn-SIM2-23 ( Figure 4A ), and their mock-transfected counterparts, KYSE510-Mock, TE8-Mock, T.Tn-Mock. Given that PDPN is a basal cell marker in normal esophageal mucosa 26, 27 and is also a marker of tumor basal cells with high tumor-initiating ability in squamous cell carcinoma, 28 we compared the proportion of PDPN-positive cells in the SIM2-transfectants to that in the mock transfectants by flow cytometry using anti-PDPN antibody.
We first confirmed that there was no difference between the PDPN-positive tumor basal cell ratios of mock-and SIM2-transfectants stained with control IgG (data not shown). The PDPN-positive tumor basal cell ratio in KYSE510-Mock was 50.6%, whereas that in KYSE510-SIM2-27 and KYSE510-SIM2-37 was markedly reduced 
| SIM2 induces well-differentiated histology
To investigate the effect of SIM2 on tumor formation, we trans- 
| DISCUSSION
Epigenetic changes in DNA without concomitant changes in the underlying genetic code are known to occur in human cancers. 31 Promoter methylation resulting in repression of tumor suppressor genes may drive tumorigenesis. We found that SIM2 expression is repressed in cancerous tissues compared with non-cancerous tissues in 90% of 60 ESCC patients ( Figure 1A,B) . Promoter hypomethylation of SIM2 was found in 4 of 5 ESCC cases with high SIM2 expression, whereas hypermethylation was found in 3 of 5 cases with low SIM2 expression ( Figure 2C ). Therefore, promoter methylation is thought to be one of the causes that represses SIM2 in ESCC.
We showed that overexpression of the long isoform of SIM2 decreased the expression of the major EMT regulators, SNAI2 and TWIST1, whereas the short splicing isoform SIM2s did not affect their expression ( Figure 3A) . Therefore, the SIM2 long isoform is In addition, immunofluorescence and immunoprecipitation of transient or stable SIM2-transfectants showed that SIM2 is localized F I G U R E 7 Sensitivity of SIM2-transfectants to CDDP and H 2 O 2 is associated with decreased expression of DNA repair and antioxidant enzymes. A, Viable cell ratios of T.Tn-Mock, T.Tn-SIM2-9 and T.Tn-SIM2-23 cells that were treated with alternate day administration of CDDP in 3D culture for 14 days (n = 3, mean + SE; *P < .05). B, Viable cell ratios of TE8-Mock (white column) and TE8-SIM2-2 cells (red column) that were treated with H 2 O 2 in 3D culture for a day (n = 3, mean + SE; *P < .05). C, Real-time RT-PCR of FANCD2, BRAC1, BARD1, XRCC5, and SOD2 in 3D cultured TE8-Mock (white column) and TE8-SIM2-2 (red column) cells (n = 3, mean + SE; *P < .05). D, Real-time RT-PCR of SOD2 (left) and viable cell ratios in fluorouracil (5-FU) (middle) or H 2 O 2 (right) treatment in TE8 that were transfected with control siRNA (white column) or SOD2 siRNA (red column) (n = 3, mean + SE; *P < .05)
in the nuclei and interacted with ARNT (Figure 6A,B; S4) . Furthermore, knockdown of ARNT expression in the transient or stable Microvessel density in squamous cell carcinoma has been reported to be associated with radiosensitivity. 37 Such microvessels were often observed in the thick stroma in well-differentiated ESCC ( Figure S10A ) and also in the xenograft with a well-differentiated histology of KYSE510 cells ( Figure S10B ). Interestingly, the xenograft of the SIM2-transfectant T.Tn-SIM2-9 also showed increased angiogenesis ( Figure S10C ). Tumor angiogenesis is another complex phenotype at the crossroads of multiple intra-and extracellular signaling, and it is possible that SIM2 stimulates angiogenesis indirectly but contributes to chemo-and radiosensitivity through delivery of CDDP and oxygen to tumor basal cells in vivo.
We summarized possible SIM2 roles in good (left) and poor 
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